Veridix

Veridix is Emmes Group's technology and AI division, delivering industry-leading eClinical Cloud solutions for clinical research and development. The platform integrates electronic data capture (EDC), randomization and trial supply management (RTSM), decentralized clinical trial capabilities, and patient-reported outcomes (eCOA/ePRO) into a unified, AWS-native application built on a single CDISC-compliant database.

Key Capabilities:

• eClinical Cloud Platform: Single unified application for study design, data capture, randomization, and reporting with mobile-centric user experience and multi-modal access.
• AI-Powered Data Management: Automated data ingestion, monitoring, and correction; AI-based recommendations for edit checks and data entry; integrated coding to MedDRA and WHODrug dictionaries.
• Decentralized Trial Support: Health Navigator and remote source data verification (SDV) capabilities enabling site and patient flexibility.
• AI Agents: Biostats and Analysis Agent, Data Management Agent, and Document Authoring Agent for automating clinical workflows.
• Analytics & Reporting: GlobalTrace, Clinical Pipelines, and VERA (AI reporting agent) for real-time visibility and KPI tracking.

Veridix has supported 2,150+ Phase I–IV trials across 90+ countries and generated 434+ publications in scientific journals since 2016. The platform emphasizes faster study launch, mid-study changes without downtime, and streamlined collaboration between sponsors, CROs, and clinical sites.